However, the ratio of M1 macrophage (anti-tumoral)-specific genes (n = 8) to M2 (pro-tumoral) macrophage-specific genes (n = 8) was shown to be marked lower only in LGG with high TRIP13 level, but there was no significant change in GBM (Figure 11E,F, Table S7). This evidence concerns the gene TRIP13 and glioblastoma.